Graf Akcie EGRX (Eagle Pharmaceuticals Inc). Diskuze k akciím EGRX. Aktuální informace EGRX.

Základní informace o společnosti Eagle Pharmaceuticals Inc (Akcie EGRX)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 713.41M
Hodnota podniku (EV) N/A
Tržby 189.217M
EBITDA N/A
Zisk 18.307M
Růst v tržbách Q/Q 14.75 %
Růst v tržbách Y/Y 6.68 %
P/E (Cena vůči ziskům) 39.69
Forward P/E 42.61
EV/Sales 3.23
EV/EBITDA N/A
EV/EBIT 30.93
PEG 15.44
Price/Sales 3.83
P/FCF 16.61
Price/Book 3.89
Účetní hodnota na akcii 13.97
Hotovost na akcii 7.75
FCF vůči ceně 6.05 %
Počet zaměstnanců 106
Tržba na zaměstnance 1785000
Profit margin 6.38 %
Operating margin 17.05 %
Gross margin 75.79 %
EBIT margin 15.30 %
EBITDA margin 14.22 %
EPS - Zisk na akcii 1.37
EPS - Kvartální růst 63.16 %
EPS - Očekávaný růst příští rok -28.21 %
Return on assets 7.14 %
Return on equity 9.83 %
ROIC 9.95 %
ROCE 13.18 %
Dluhy/Equity 0.36
Čistý dluh/EBITDA -9.58
Current ratio 3.93
Quick Ratio 3.74
Volatilita 3.47
Beta 0.72
RSI 51.19
Cílová cena analytiků 50
Známka akcie (dle analytiků) N/A
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 13.097M
Procento shortovaných akcií 11.72 %
Short ratio 10.73 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2014
Země United States

Finanční výsledky akcie EGRX

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$195.892$213.312$236.707$189.482$66.227-
Cost Of Goods Sold$60.897$61.916$57.186$55.306$15.647-
Gross Profit$134.995$151.396$179.521$134.176$50.58-
Research And Development Expenses$36.81$44.419$32.607$28.289$27.855-
SG&A Expenses$76.37$60.509$71.416$53.329$20.165-
Other Operating Income Or Expenses-$-1.941$-1.508$0.793--
Operating Expenses$174.077$176.696$162.717$136.131$63.667-
Operating Income$21.815$36.616$73.99$53.351$2.56-
Total Non-Operating Income/Expense$0.183$-2.578$-1.045$0.076$0.014-
Pre-Tax Income$21.998$34.038$72.945$53.427$2.574-
Income Taxes$7.685$2.135$21.002$-28.026$0.003-
Income After Taxes$14.313$31.903$51.943$81.453$2.571-
Other Income------
Income From Continuous Operations$14.313$31.903$51.943$81.453$2.571-
Income From Discontinued Operations------
Net Income$14.313$31.903$51.943$81.453$2.571-
EBITDA$26.946$40.662$77.959$54.94$2.672-
EBIT$21.815$36.616$73.99$53.351$2.56-
Basic Shares Outstanding1415151615-
Shares Outstanding1415161616-
Basic EPS$1.04$2.16$3.44$5.24$0.17-
EPS - Earnings Per Share$1.01$2.09$3.27$4.96$0.16-
# 2020 2019 2018 2017 2016 2015
Current Ratio4.62224.12853.98922.66353.5683-
Long-term Debt / Capital0.15770.19180.1932---
Debt/Equity Ratio0.21520.27620.2667---
Gross Margin68.91370.97475.84170.81276.3737-
Operating Margin11.136217.165531.258128.15623.8655-
EBIT Margin11.136217.165531.258128.15623.8655-
EBITDA Margin13.755519.062232.934828.99484.0346-
Pre-Tax Profit Margin11.229715.956930.816628.19643.8866-
Net Profit Margin7.306614.95621.94442.98723.8821-
Asset Turnover0.76950.8940.87650.88410.5315-
Inventory Turnover Ratio9.27467.456211.173520.1921.0402-
Receiveable Turnover4.08073.20844.3984.49072.5213-
Days Sales In Receivables89.4445113.764882.991581.2785144.7666-
ROE - Return On Equity7.988319.844928.995153.86182.8458-
Return On Tangible Equity11.556930.999144.748104.27852.8458-
ROA - Return On Assets5.622813.370719.233938.00532.0633-
ROI - Return On Investment6.728216.038423.392653.86182.8458-
Book Value Per Share13.145611.55412.06369.86865.7779-
Operating Cash Flow Per Share0.5312-0.27520.46613.8355-0.59791.3904
Free Cash Flow Per Share0.4849-0.00510.57923.5593-0.71361.395